A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Public ClinicalTrials.gov record NCT03558503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Single-Arm, Multicenter Trial to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients With Low Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) at Intermediate Risk of Recurrence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2b, single-arm, multicenter study evaluated the efficacy and safety of UGN-102 as primary chemoablative therapy in patients with low grade intermediate risk non-muscle-invasive bladder cancer (LG IR NMIBC).
Study identification
- NCT ID
- NCT03558503
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 63 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2018 (Actual)
- Primary completion
- Jan 3, 2020 (Actual)
- Completion
- Oct 21, 2020 (Actual)
- Last update posted
- Sep 16, 2022
2018 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Cancer Center | Phoenix | Arizona | 85054 | — |
| Arkansas Urology | Little Rock | Arkansas | 72211 | — |
| Loma Linda University | Loma Linda | California | 92350 | — |
| Providence Medical Institute | Santa Monica | California | 90404 | — |
| Clinical Research Center of Florida | Pompano Beach | Florida | 33060 | — |
| John Hopkins University | Baltimore | Maryland | 21218 | — |
| Adult & Pediatric Urology, PC | Omaha | Nebraska | 68114 | — |
| Urology Las Vegas | Las Vegas | Nevada | 89144 | — |
| Manhattan Medical Research | New York | New York | 10016 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Montefiore Medical Center (Albert Einstein) | New York | New York | 10461 | — |
| Western New York Urology Associates | New York | New York | 14225 | — |
| The University of North Carolina | Chapel Hill | North Carolina | 27572 | — |
| Penn State Hershey State College | Hershey | Pennsylvania | 17033 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates, PC | Nashville | Tennessee | 37209 | — |
| Urology San Antonio | Fredericksburg | Texas | 78233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03558503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03558503 live on ClinicalTrials.gov.